Milestone in Beijing: Peking University Third Hospital issued the region's first prescription of Ensifentrine

Milestone in Beijing: on October 15, 2026, Peking University Third Hospital issued the region's first prescription of Ensifentrine, following its inclusion in the catalog of clinically urgent imported medicines.

Ensifentrine is a PDE3/PDE4-targeted COPD therapy, originally developed by Verona Pharma and FDA-approved in June 2024.

#COPD #Ensifentrine #RespiratoryHealth